Teva Pharmaceutical Industries Limited (TEVA) News Headlines

▮ More

Date

Headline

9/16/2019 1:00:02 AM Canndoc Signs Medical Marijuana Distribution Deal With Teva Subsidiary

9/13/2019 5:38:17 AM InterCure: S.L.E. To Distribute Canndoc's GMP Products In Israel

9/13/2019 5:04:17 AM CANNDOC Signs Strategic Distribution Agreement With S.L.E. Of TEVA Pharma

8/7/2019 7:19:57 AM Teva Q2 Loss Per Share $0.63 Vs Loss $0.24 Last Year

8/7/2019 7:15:22 AM Teva Pharmaceutical CFO Michael McClellan To Step Down - Quick Facts

8/7/2019 7:09:35 AM Teva Pharmaceutical Industries Limited Q2 adjusted earnings Beat Estimates

8/7/2019 7:08:03 AM Teva CFO Michael McClellan To Step Down Due To Personal Reasons

8/7/2019 7:00:06 AM Teva Pharmaceutical Q2 19 Earnings Conference Call At 8:00 AM ET

7/15/2019 8:57:54 AM Teva Pharma Announces FDA Approval Of AirDuo Digihaler - Quick Facts

7/15/2019 8:36:53 AM Teva Announces FDA Approval Of AirDuo Digihaler Inhalation Powder

7/2/2019 2:34:23 AM Teva To Present FOCUS Exploratory Endpoints Results

7/1/2019 8:41:18 AM Teva Announces Launch Of 1% Sodium Hyaluronate In The U.S.

5/28/2019 2:35:07 PM Teva Stock Downgraded To Neutral By UBS, Stock Down 12%

5/2/2019 7:14:48 AM Teva Pharmaceutical Industries Limited Q1 adjusted earnings Beat Estimates

5/2/2019 7:04:58 AM Teva Q1 Non-GAAP EPS $0.60; GAAP Loss Per Share $0.10

5/2/2019 7:00:17 AM Teva Pharmaceutical Q1 19 Earnings Conference Call At 8:00 AM ET

4/23/2019 9:19:37 AM Teva To Discontinue Fremanezumab Development Program - Quick Facts

4/23/2019 9:09:48 AM Compass Minerals Names Kevin Crutchfield President And CEO

4/23/2019 9:07:54 AM Teva Discontinues Clinical Development Program For Use Of Fremanezumab In Cluster Headaches

4/10/2019 8:11:36 AM Teva Enters New $2.3 Bln Unsecured Revolving Credit Facility